DigestRedComo funciona
Red
/
Empresas
Tu
No verificado

Tubulis

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaOncologíaSalud

10 Comunicados de prensa

Ver todos los comunicados de prensa
30/10/2025
Biotecnología
Sanidad
Salud
Farmacéutica
Oncología
Ciencia
Ir de compras
Medicina - Varios
Tubulis Announces Second Closing of Series C Bringing Total Raised to €344M (US $401M)
Fuente
Tubulis
Editor
Business Wire
1.00
0
19/10/2025
Ciencia
Medicina - Varios
Biotecnología
Farmacéutica
Ir de compras
Salud
Oncología
Eventos
Industria
Tubulis Presents First Clinical Data from Phase I/IIa Trial for TUB-040 in Platinum-Resistant Ovarian Cancer (PROC) at ESMO 2025
Fuente
Tubulis
Editor
Business Wire
1.00
0
15/10/2025
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Tubulis Raises €308 Million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline
Fuente
Tubulis
Editor
Business Wire
1.00
0
22/09/2025
Eventos
Industria
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Tubulis to Present First Phase I/IIa Trial Data for ADC Candidate TUB-040 in Platinum-Resistant Ovarian Cancer in Late-Breaking Oral Presentation at ESMO 2025
Fuente
Tubulis
Editor
Business Wire
1.00
0
09/09/2025
Ciencia
Legislación/Derecho
Biotecnología
Farmacéutica
Oncología
Salud
Asociaciones/Profesionales
Mercado laboral
Tubulis Strengthens Leadership Team with Appointment of Halley Gilbert as Chief Legal and Operating Officer
Fuente
Tubulis
Editor
Business Wire
1.00
0
06/02/2025
Oncología
Salud
Ciencia
Farmacéutica
Biotecnología
Mercado laboral
Tubulis Strengthens Executive Leadership with Appointment of Matthew Norkunas as Chief Financial Officer and President of Tubulis Inc.
Fuente
Tubulis
Editor
Business Wire
1.00
0
30/01/2025
Ciencia
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Oncología
Industria
Tubulis Announces First Patient Dosed in Phase I/IIa Trial Evaluating ADC TUB-030 in Advanced Solid Tumors
Fuente
Tubulis
Editor
Business Wire
1.00
0
17/12/2024
Eventos
Biotecnología
Farmacéutica
Salud
Oncología
Tubulis to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Fuente
Tubulis
Editor
Business Wire
1.00
0
05/08/2024
Ciencia
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Sanidad
Oncología
Eventos
Industria
Fierce Biotech Names Tubulis a "Fierce 15" Biotech Company of 2024
Fuente
Tubulis
Editor
Business Wire
1.00
0
27/06/2024
Industria
Ciencia
Higiene alimentaria
Medicina - Varios
Biotecnología
Sanidad
Farmacéutica
Salud
Oncología
Tubulis Receives FDA Fast Track Designation for Antibody-Drug Conjugate Candidate TUB-040 in Platinum-resistant Ovarian Cancer
Fuente
Tubulis
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0